JP2023514606A5 - - Google Patents

Info

Publication number
JP2023514606A5
JP2023514606A5 JP2022549677A JP2022549677A JP2023514606A5 JP 2023514606 A5 JP2023514606 A5 JP 2023514606A5 JP 2022549677 A JP2022549677 A JP 2022549677A JP 2022549677 A JP2022549677 A JP 2022549677A JP 2023514606 A5 JP2023514606 A5 JP 2023514606A5
Authority
JP
Japan
Prior art keywords
approximately
therapeutic agent
less
pharmaceutically acceptable
nanoparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022549677A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023514606A (ja
JP7756097B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/018466 external-priority patent/WO2021168043A1/en
Publication of JP2023514606A publication Critical patent/JP2023514606A/ja
Publication of JP2023514606A5 publication Critical patent/JP2023514606A5/ja
Application granted granted Critical
Publication of JP7756097B2 publication Critical patent/JP7756097B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022549677A 2020-02-19 2021-02-18 治療剤ナノ粒子および調製方法 Active JP7756097B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062978773P 2020-02-19 2020-02-19
US62/978,773 2020-02-19
PCT/US2021/018466 WO2021168043A1 (en) 2020-02-19 2021-02-18 Therapeutic agent nanoparticles and methods of preparation

Publications (3)

Publication Number Publication Date
JP2023514606A JP2023514606A (ja) 2023-04-06
JP2023514606A5 true JP2023514606A5 (https=) 2024-02-27
JP7756097B2 JP7756097B2 (ja) 2025-10-17

Family

ID=77391611

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022549677A Active JP7756097B2 (ja) 2020-02-19 2021-02-18 治療剤ナノ粒子および調製方法

Country Status (9)

Country Link
US (1) US12370145B2 (https=)
EP (1) EP4106731A4 (https=)
JP (1) JP7756097B2 (https=)
KR (1) KR20220144378A (https=)
CN (2) CN119345135A (https=)
AU (1) AU2021221987B2 (https=)
CA (1) CA3166756A1 (https=)
IL (1) IL295268A (https=)
WO (1) WO2021168043A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240000717A1 (en) * 2020-11-19 2024-01-04 Nano Pharmasolutions, Inc. Dry powder antiviral compositions and their use for treating viral infection
WO2023086903A1 (en) * 2021-11-10 2023-05-19 Nano Pharmasolutions, Inc. Cannabidiol nanoparticle compositions
WO2025259725A1 (en) * 2024-06-11 2025-12-18 Nano Pharmasolutions, Inc. Apomorphine compositions and therapeutic applications

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1200693C (zh) 1998-11-18 2005-05-11 佛罗里达大学 制备包衣药粒及药物制剂的方法
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
KR100644219B1 (ko) 2004-09-16 2006-11-10 주식회사 피앤아이 나노 입자의 형성방법, 그의 장치 및 그의 응용제품
EP2010153A2 (en) * 2006-04-03 2009-01-07 Teva Pharmaceutical Industries Limited Drug microparticles
WO2008045022A2 (en) 2006-08-09 2008-04-17 Luna Innovations Incorporated Additive particles having superhydrophobic characteristics and coatings and methods of making and using the same
EP2050437A1 (en) 2007-10-15 2009-04-22 Laboratoires SMB Improved pharmaceutical dry powder compositions for inhalation.
JP2011515444A (ja) * 2008-03-25 2011-05-19 フォーマック ファーマシューティカルズ ナムローゼ フェンノートシャップ 固体分散体の調製方法
WO2012147901A1 (ja) * 2011-04-28 2012-11-01 味の素株式会社 抗癌剤副作用改善用組成物
MX351059B (es) * 2012-08-17 2017-09-29 Laboratorios Senosiain S A De C V Star Composicion farmaceutica oral en forma de microesferas y proceso de elaboracion.
US9801820B2 (en) 2012-11-12 2017-10-31 New Jersey Institute Of Technology Pharmaceutical core-shell composite powder and processes for making the same
US10030292B2 (en) * 2014-05-26 2018-07-24 Hrl Laboratories, Llc Hydride-coated microparticles and methods for making the same
GB201506381D0 (en) 2015-04-15 2015-05-27 Isis Innovation Embolization particle

Similar Documents

Publication Publication Date Title
JP2023514606A5 (https=)
JP7042015B2 (ja) 経口投与型コルチコステロイド組成物
JP2023526098A5 (https=)
CA2658521C (en) Enhanced immediate release formulations of topiramate
JP6106187B2 (ja) アゾール誘導体の吸入用乾燥粉末製剤
ES2312308T1 (es) Formulaciones de liberacion sostenida de topiramato.
JP2011052021A (ja) 鼻腔送達用医薬品組成物
TWI849062B (zh) 保存水性懸浮液中以無溶劑混合方法製備的功能性塗覆之活性醫藥成份微粒
TWI286942B (en) Rapidly disintegrating tablet and preparing method thereof
TW202214299A (zh) 包含Akt蛋白質激酶抑制劑之醫藥組合物
CN115969858A (zh) 药物组合物及其制备方法和用于治疗冠状病毒引起的疾病的用途
CN117580803A (zh) 用于药物递送的硅颗粒
KR102363727B1 (ko) 생체이용률이 개선된 프란루카스트 함유 고형 제제의 조성물 및 그 제조방법
US20260000683A1 (en) Sustained-release injectable composition containing dutasteride
EP3257511A1 (en) Intraoral rapid disintegration tablet and method for manufacturing same
CN106999429B (zh) 纳米悬浮剂制剂
JP2024543125A5 (https=)
CN107427462B (zh) 固态分散体
JP2015071542A (ja) 固体分散体の製造方法
EP4313155A1 (fr) Formulation par voie orale d'ivermectine et utilisations
CN1927183B (zh) 抗肿瘤药物表阿霉素缓释微球制剂及制备方法
Deepika et al. A review on orally disintegrating tablets
EP3582760A1 (en) Pharmaceutical composition comprising an antiemetic agent and method for the preparation thereof
Khan et al. REVIEW OF ORODISPERSIBLE TABLET USING NOVEL CO-PROCESSING METHOD
KR20140094762A (ko) 나프로닐을 포함하는 고체 분산체 및 이의 제조방법